Current role
James Alecxih
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About James Alecxih
TriSalus Life Sciences, Inc. reported in an 8-K filed August 16, 2023 that James Alecxih was appointed President, Device Technology, effective August 10, 2023.
“Immediately following Closing, the New TriSalus Board appointed the following individuals as the Company's executive officers: Mary Szela to serve as Chief Executive Officer and President, Sean Murphy to serve as Chief Financial Officer, James Alecxih to serve as President, Device Technology, Steven Katz to serve as Chief Medical Officer, Bryan Cox to serve as Chief Scientific and Manufacturing Officer, Jennifer Stevens to serve as Chief Regulatory Officer, and Richard Marshak to serve as Senior Vice President, Corporate Development & Strategy.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-08-10–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at TriSalus Life Sciences, Inc.
Other people whose current roles at this company are on record from its filings.
- Mary Szela CEO, Board Member
- Karim Karti Chairman
- Mats Wahlström Chairman, Board Member
- David B. Patience CFO
- David Patience CFO
- James Young CFO, Head of Investor Relations
- Andrew von Eschenbach Board Member
- Anil Singhal Board Member
- Arjun Desai Board Member
- Gary Gordon Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.